Drug Rebates, Impact On Premiums Must Be Disclosed Under COVID Stimulus Law

Medicare Part B payment loopholes also targeted in law, and Medicare Part D plans will need to offer real-time benefit tools for prescriber-patient decision making.

New Drug Price Discounting And Reporting Requirements

Future US policy debates regarding the connection between prescription drug rebates and insurance costs will be informed by a transparency requirement tucked into the $900bn economic stimulus and US government funding bill signed into law on 28 December.

Known as the Consolidated Appropriations Act, the law directs government sponsored and commercial health plans to report manufacturer rebates...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet